NEW YORK–(BUSINESS WIRE)–The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the redeemable warrants of ATI Physical Therapy, Inc. (the “Company”), each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (the “Warrants”)— ticker symbol ATIP WS — from the NYSE. Trading in the Company’s Warrants will be suspended immediately. Trading in the Company’s Class A common stock — ticker symbol ATIP — will continue on the NYSE.
NYSE Regulation has determined that the Company’s Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
Contacts
Company Contacts:
Investor Relations
Joanne Fong
SVP, Treasurer and Head of Investor Relations
ATI Physical Therapy
[email protected]
630-296-2223 ext. 7131
Media
Genesa Garbarino
Garbo Communications
[email protected]
424-499-7025
Rob Manker
Director Marketing & Public Relations
ATI Physical Therapy
[email protected]
630-296-2222 ext. 7432
NYSE Contact:
NYSE Communications
[email protected]
